When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. AstraZeneca - Wikipedia

    en.wikipedia.org/wiki/AstraZeneca

    AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [13]

  3. List of companies based in the Philadelphia area - Wikipedia

    en.wikipedia.org/wiki/List_of_companies_based_in...

    Name City Industry Fortune 500 rank (2009) Notes ACE USA: Philadelphia: insurance: Arkema: Philadelphia: chemicals: AstraZeneca: Wilmington, DE: pharmaceuticals

  4. AstraZeneca to invest $300 million in US facility for cell ...

    www.aol.com/news/astrazeneca-invest-300-million...

    (Reuters) -AstraZeneca said on Tuesday it will invest $300 million in a facility in Rockville, Maryland, for discovery and development of cell therapies.

  5. Alexion Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Alexion_Pharmaceuticals

    Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases.

  6. AstraZeneca to Establish Strategic R&D Center in ... - AOL

    www.aol.com/2013/03/18/astrazeneca-to-establish...

    For more information about AstraZeneca in the U.S. or our AZ&Me™ Prescription Savings programs, please visit: www.astrazeneca-us.com or call 1-800-AZandMe (292-6363). AstraZeneca Media Inquiries:

  7. AstraZeneca becomes first international company to file ... - AOL

    www.aol.com/finance/astrazeneca-becomes-first...

    AstraZeneca joins as the sixth pharma company, and the first non-US company, to file suit against the Biden Administration over Medicare drug pricing.

  8. MedImmune - Wikipedia

    en.wikipedia.org/wiki/MedImmune

    MedImmune, LLC was a wholly owned subsidiary of AstraZeneca before February 14, 2019, when it was announced that the MedImmune name and branding would be discontinued in favor of AstraZeneca. [1] [2] MedImmune was founded in 1988 as Molecular Vaccines, Inc, and was purchased in 2007 for $15.6 billion. [3]

  9. AstraZeneca prioritizes US for RSV drug amid surge in cases - AOL

    www.aol.com/news/astrazeneca-prioritizes-us-rsv...

    AstraZeneca on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus, which was approved in July to prevent the disease in ...